Psychotherapist, adventurer. Often found up mountains on a horse. Interested in neuroscience and the link between nature and mental health. All views my own.
Inside out: the neural basis of spontaneous and creative thinking
New scientific commentary by Alizée Lopez-Persem, Emmanuel Mandonnet & Emmanuelle Volle https://t.co/ytvLAEjMFX
Study confirms what any parky will tell you.. stress worsens #parkinsons symptoms including tremor, sleep problems, depression, dyskinesia, freezing, bradykinesia, cognition, executive impairment, confusion, loss of focus, speech, anxiety, apathy & pain https://t.co/60xI3ye9uD.
Martijn Muller of the Critical Path for Parkinson’s at Rallying to the Challenge talking about the vital work they do with clinical trial outcomes and biomarkers. @VAInstitute @CureParkinsonsT
New research from @VJoers @MaluTansey & colleagues reports that 7 weeks of peripheral administration of an inverse cannabinoid receptor-2 agonist modulates inflammatory & immune responses an a-synuclein model of #Parkinsons
https://t.co/8Kww8LnZtq
A fantastic initiative from @CureParkinsonsT (well done Anaya) and data will inform neurological trials more generally. With thanks to QMU, and colleagues @Parkinson’s UK for disseminating
"There is much research to be done to ensure their [biomarkers] appropriate & effective use in clinical settings. The neuropathology community is eager to work with our clinical & neuroimaging colleagues to achieve this important goal" - Preach!
You don't see objective reality objectively: neuroscience catches up to philosophy
Objective reality exists, but what can you know about it that isn’t subjective. According to some neuroscientists, not much. #reality https://t.co/jM9rGyUiB2
Want to get involved in research, but aren't sure where to start? Take a look at People in Research and browse opportunities from across the UK: https://t.co/MAtWeJP6wF
Great to be @ the @EJS_ACT_PD annual meeting! @foltynie & @CamilleBCarroll are opening proceedings with an update (& celebration!) of what has been achieved thus far in the consortiums efforts to build a MAMS platform for clinical trials of disease modifying drugs for #Parkinsons
I had such a great day too, very positive, greatly uplifting and genuinely inspiring for all to continue with the excellent initiative @EJS_ACT_PD are working with 🧑🏼🔬👨🏽🔬⚛️🔬
Shafaq and Kuhan, it's always a pleasure to see you too, you truly are two of the very loveliest of people there are (and fantastic shoes Shafaq 👞👞)
So many great people to thank for the day, and the continuing establishment of a clinical trial research programme on stopping the progression of #Parkinsons 🧡
@Dr_SF_Hussain@morethanatremor@CureParkinsonsT@ParkinsonsUK@foltynie@CamilleBCarroll@HelenMatthewsQ
Amazing day! What an inspirational group of people! So much has been achieved already with @EJS_ACT_PD! Congrats to @CamilleBCarroll@foltynie & team on fantastic progress. The future of #Parkinsons clinical trial research looked bright today. @CureParkinsonsT is proud to support
This week we’re supporting @ParkinsonsUK with the ‘Parkinson’s Research Needs You’ campaign! Read how we’ve been working together to improve Parkinson’s research, and bring forward new treatments for Parkinson’s, faster: https://t.co/4BkFy5gxpD
#ParkinsonsResearchNeedsYou
@MichaelOkun@NatureMedicine@NEJM One question that lingers still (6 years later): is the primary effect of GLP-1 agonists truly on microglia, and not directly on astrocytes (see below) or neurons?
Has anyone else seen direct effects on microglia?
@brundin_lena
https://t.co/vBTBJ517na
This connectivity and dedication to research into #parkinson’s is why @CureParkinsonsT is so pleased to support this network and proud of all it is achieving. @ScienceofPD